Wasatch Advisors Reduces Stake in MacroGenics (MGNX) Below 5%
MACROGENICS INC
Subscribe to track MGNX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Wasatch Advisors Reduces Stake in MacroGenics (MGNX) Below 5%
Company: MACROGENICS INC (MGNX) Form: SCHEDULE 13G/A | Filed: 2025-11-12 Significance: Medium
Investor: Wasatch Advisors LP Title: Investment Adviser | Relationship: Beneficial Owner
Holdings Update: • Type: Change in Holdings • Shares Owned After: 1,950,287 • Ownership %: 3.1%
Key Insight: Institutional investor Wasatch Advisors has reduced its position in MGNX, falling below the 5% ownership reporting threshold. This signals a significant decrease in their holdings.
Market Context: For a nano-cap company like MGNX ($90M market cap), the reduction of a significant institutional stake can negatively impact investor sentiment and may warrant further investigation into the company's recent performance.
Comprehensive Analysis
SEC Filing Analysis: MACROGENICS INC (MGNX)
Executive Summary
- Trading Significance: Medium
- Key Takeaway: Institutional investor Wasatch Advisors LP filed a Schedule 13G/A indicating its ownership in MacroGenics has fallen to 3.1%, dropping below the 5% reporting threshold.
- Market Impact: This is a potentially bearish signal for the nano-cap stock, as it shows a significant institutional holder has been reducing its position.
Company Information
| Field | Value |
|---|---|
| Company | MACROGENICS INC |
| Ticker Symbol | MGNX |
| CIK | 0001125345 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | Wasatch Advisors LP |
| CIK | 0000814133 |
| Title/Position | Investment Adviser |
| Relationship | Beneficial Owner |
Transaction Details
| Field | Value |
|---|---|
| Form Type | SCHEDULE 13G/A |
| Transaction Date | Not Applicable |
| Transaction Code | Not Applicable |
| Security Type | Common Stock |
| Shares Involved | Not specified |
| Price Per Share | Not specified |
| Total Value | Not specified |
| Shares Owned After | 1,950,287 |
| Ownership Type | Not specified |
Financial Impact Assessment
Transaction Materiality
This filing reports a change in aggregate holdings rather than a single transaction. The key event is the filer's ownership percentage dropping below the 5% threshold.
| Metric | Value |
|---|---|
| Post-Transaction Ownership | 1,950,287 shares |
| % of Shares Outstanding | 3.1% |
| Materiality Assessment | Medium |
Impact Evaluation
- Market Cap Context: MacroGenics is a nano-cap company with a market capitalization of approximately $90 million. In this context, the actions of institutional investors carry significant weight, and the exit of a major holder can create negative pressure on the stock.
- Ownership Concentration: The filing indicates a decrease in institutional ownership concentration. The reduction of a position by a named fund like Wasatch Advisors can be a notable event for other market participants.
- Transaction Significance: The significance lies not in a single transaction's value but in the strategic decision by an institutional investor to reduce their stake below a key reporting level. This implies the sale of a substantial number of shares over time, signaling a decreased conviction in the investment.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: While the reduction of a major stake is often a bearish indicator, this filing reports a state of ownership as of a past date (09/30/2025). The market may have already priced in the associated selling pressure. However, the official confirmation can still negatively influence sentiment.
Volume & Sentiment
- Expected Volume Impact: Minimal direct impact, as the selling has already occurred. However, it could influence future trading decisions by other investors.
- Sentiment Indicator: Neutral to Bearish. The news confirms that a significant institutional investor has been selling, which is a fundamentally bearish data point.
Investment Insights
Positive Market Indicators
- None are indicated by this filing.
Risk Factors
- Loss of Institutional Support: The reduction of Wasatch Advisors' stake below 5% signals a loss of conviction from a professional asset manager.
- Potential for Further Selling: It is unknown if Wasatch Advisors has completely liquidated its position or intends to sell its remaining 3.1% stake.
- Negative Signaling: For a small-cap biotech firm, such a move can be interpreted by the market as a negative signal regarding the company's pipeline, financial health, or future prospects.
Key Takeaways
- Stake Reduction: Wasatch Advisors is no longer a greater-than-5% beneficial owner of MacroGenics.
- Bearish Signal: The exit of a significant institutional holder is a noteworthy event that can weigh on investor sentiment, particularly for a nano-cap stock.
- Context is Key: This filing confirms a change that has already taken place. Investors should analyze it in the context of the company's recent performance and news to understand the potential drivers behind Wasatch's decision.
Additional Context
Transaction Notes
- This Schedule 13G/A is an amendment to a prior filing, triggered by the filer's ownership level falling below 5%. The filing indicates a passive investment purpose, meaning the shares were not held to influence control of the company.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
